Compare MASS & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASS | SPOK |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.0M | 267.8M |
| IPO Year | 2020 | 1992 |
| Metric | MASS | SPOK |
|---|---|---|
| Price | $6.35 | $13.46 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 378.4K | 158.2K |
| Earning Date | 03-03-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 9.27% |
| EPS Growth | N/A | ★ 12.68 |
| EPS | N/A | ★ 0.80 |
| Revenue | $65,045,000.00 | ★ $139,739,000.00 |
| Revenue This Year | N/A | $4.11 |
| Revenue Next Year | $19.55 | $2.63 |
| P/E Ratio | ★ N/A | $16.84 |
| Revenue Growth | ★ 36.21 | 1.47 |
| 52 Week Low | $1.92 | $12.26 |
| 52 Week High | $9.34 | $19.31 |
| Indicator | MASS | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 52.59 | 53.22 |
| Support Level | $6.06 | $13.36 |
| Resistance Level | $6.90 | $13.84 |
| Average True Range (ATR) | 0.41 | 0.29 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 41.67 | 57.32 |
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.